Experts say ‘secondary use’ of data could prove primary

To overcome elusive ROI figures on electronic medical record projects, vendors have been touting the value of digitized data for secondary uses such as drug recall notification and post-release pharmaceutical studies.

But as a panel of experts assembled in the nation’s capital pointed out on Monday, calling those applications “secondary” betrays a limiting perspective on technology.

Leave a Reply

Your email address will not be published. Required fields are marked *